Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Website URL
Similar Companies1000
Strongbridge Biopharma
Strongbridge Biopharma is a biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
Sector
Subsector
Location
total rounds
total raised
ViroPharma
ViroPharma is a biopharmaceutical company that develops and commercializes products for serious diseases.
Sector
Subsector
Keywords
Location
total rounds
Xenoport
XenoPort is a biopharmaceutical company that develops treatments for neurological disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
Anthera Pharmaceuticals
Anthera Pharmaceuticals develops and sells treatments for inflammation-related diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Actelion Pharmaceuticals
announced date
price
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 14.10.2003. Their latest investor Sofinnova Investments. Their latest round Series C
Thomas Weisel Venture Partners
Thomas Weisel Venture Partners is an early stage venture capital firm that invests in emerging information technology companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Frazier Healthcare Partners
Frazier Healthcare Partners is a private equity firm that provides growth and venture capital to healthcare companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Sofinnova Partners
Sofinnova Partners is a venture capital firm that invests in life sciences.
Sector
Subsector
Location
total rounds
count Of Investments
count Of Exists
MPM Capital
MPM Capital invests in early-stage healthcare companies developing innovative oncology technologies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors8
Number of lead investors
Number of investors
Sofinnova Investments
Sofinnova Investments is a venture capital firm that specializes in funding and supporting Life Science and Technology start-ups.
Sector
Subsector
Location
count Of Investments
count Of Exists
Thomas Weisel Venture Partners
Thomas Weisel Venture Partners is an early stage venture capital firm that invests in emerging information technology companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Vivo Capital
Vivo Capital is a global investment firm focused on healthcare, with approximately $5.8 billion in assets under management.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
David Cory
David Cory is an entrepreneur and industry veteran with 25-years experience in large pharmaceuticals, emerging stage biotechnology, and specialty pharmaceutical organizations with an established track record of operational, transactional, and financial success.Mr. Cory is currently the President and CEO of Eiger BioPharmaceuticals since 2008. He is responsible for negotiating Eiger’s multiple product licenses from Merck and Astra Zeneca. Cory was previously President and Chief Operating Officer of Prestwick Pharmaceuticals, an Orphan CNS specialty pharmaceutical company, which was acquired by Biovail Pharmaceuticals for $160 million in 2008. Cory was Co-Founder and Chief Commercial Officer at CoTherix, an Orphan Pulmonary Hypertension company, which was acquired by Actelion for $425 million in 2006. Cory began his start up career as Senior Vice President of Commercial Operations at InterMune, a public biotechnology company focused on developing Orphan products for Idiopathic Pulmonary Fibrosis. He was as a key executive in the InterMune IPO, building and managing the company’s commercial organization, in-licensing 4 products and raising over $400 million in the capital markets. Mr. Cory spent the first 12 years of his career in operating positions of increasing responsibility at The Upjohn Company, Glaxo, Glaxo Wellcome, and Glaxo Smith Kline leading teams in CNS, Critical Care, Oncology, Infectious Disease, and Respiratory therapeutic areas, where he directed 10 pharmaceutical product launches and the commercialization of 20 brands.David Cory is a graduate of the University of Cincinnati, College of Pharmacy, is board certified in Pharmacy, and holds a Masters Degree in Business Administration from the University of Maryland.
current job
organization founded
David Cory
Employee Profiles9
Klara Dickinson
VP, Regulatory Affairs and Healthcare Compliance Officer
Abhay Joshi
Vice President, Chief Technical Officer and member of the Executive Committee